ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.2079del (p.Lys693fs)

dbSNP: rs267608083
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000687847 SCV000815436 pathogenic Hereditary nonpolyposis colorectal neoplasms 2024-03-04 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Lys693Asnfs*43) in the MSH6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MSH6 are known to be pathogenic (PMID: 18269114, 24362816). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 567689). For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV002422478 SCV002729834 pathogenic Hereditary cancer-predisposing syndrome 2022-03-29 criteria provided, single submitter clinical testing The c.2079delA pathogenic mutation, located in coding exon 4 of the MSH6 gene, results from a deletion of one nucleotide at nucleotide position 2079, causing a translational frameshift with a predicted alternate stop codon (p.K693Nfs*43). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Myriad Genetics, Inc. RCV003453421 SCV004188292 pathogenic Lynch syndrome 5 2023-08-16 criteria provided, single submitter clinical testing This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.
Molecular Genetics Lab, CHRU Brest RCV003883159 SCV004697604 pathogenic Endometrial carcinoma; Lynch syndrome 5; Mismatch repair cancer syndrome 3 criteria provided, single submitter clinical testing
Constitutional Genetics Lab, Leon Berard Cancer Center RCV001249958 SCV001423972 pathogenic Lynch-like syndrome 2019-07-01 no assertion criteria provided clinical testing
Genomic Center, National Cancer Institute RCV001293834 SCV001481765 pathogenic Colorectal cancer no assertion criteria provided case-control

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.